AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.28) by 25 percent. This is a 33.96 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $19.251 million which beat the analyst consensus estimate of $18.175 million by 5.92 percent. This is a 3.98 percent increase over sales of $18.514 million the same period last year.